Русский / English
Enter the query
News
Press Center
phone: +7 495 785 29 07
fax: +7 499 230 32 94
press@interros.ru
Contacts
Calendar
prev next July 2021
Mon Tue Wed Thu Fri Sat Sun
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31
Building on the success of Rosa Khutor resort, the $1 bln project will bring quality hotels and rehabilitation facilities, new skiing tracks for over a million of visitors per year while creating thousands of new jobs More Topics Interros / VEB.RF / Vasta Discovery / Sochi
Vladimir Potanin donated 500 million rubles ($6.7ml) aimed for creation of smart materials with pre-programmed properties. The project envisages establishment of a brand new Laboratory of Programmable Functional Materials, and will be carried out under the leadership of the Nobel laureate Konstantin Novoselov. More Topics Vladimir Potanin / Interros / Konstantin Novoselov / Tagir Aushev / Human Brain / Fundamental research / physics
22.07.2020
A Russian original medication called Polyoxidonium® by Petrovax, a pharmaceutical company affiliated to the Interros Group, has passed the first phase of an international clinical trial for its effectiveness and safety for COVID-19 treatment.
More Topics Petrovax Pharm
17.04.2020
Polyoxidonium (azoximer bromide) - the Russian original drug produced by Petrovax-  was approved by the Ministry of Health of the Russian Federation for conducting an international clinical trial for the treatment of COVID-19.
More Topics Petrovax Pharm
03.12.2018
The first place in the nomination «Medicine of choice for the treatment and prevention of SARS and influenza among children» was granted to «Polyoxidonium», produced by NGO Petrovax Pharm.
More Topics Petrovax Pharm